FDA Drug Recalls

Recalls / Class II

Class IID-1514-2019

Product

0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38.

Brand name
Sodium Chloride
Generic name
Sodium Chloride
Active ingredient
Sodium Chloride
Route
Intravenous
NDCs
0338-0043, 0338-0049
FDA application
NDA018016
Affected lot / code info
Lot #s: P389684; P389742, Exp. 8/31/2020

Why it was recalled

Lack of Assurance of Sterility: Bags have potential to leak.

Recalling firm

Firm
Baxter Healthcare Corporation
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1 Baxter Pkwy, N/A, Deerfield, Illinois 60015-4625

Distribution

Quantity
139,680 Containers
Distribution pattern
Nationwide in the United States and Puerto Rico.

Timeline

Recall initiated
2019-07-18
FDA classified
2019-07-23
Posted by FDA
2019-07-31
Terminated
2021-04-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1514-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.